| Unique ID issued by UMIN | UMIN000052961 |
|---|---|
| Receipt number | R000060103 |
| Scientific Title | Verification of Psychophysiological Effects Induced by Head Massage Therapy. |
| Date of disclosure of the study information | 2024/11/30 |
| Last modified on | 2023/12/01 10:24:20 |
Verification of Psychophysiological Effects Induced by Head Massage Therapy.
Verification of Psychophysiological Effects Induced by Head Massage Therapy.
Verification of Psychophysiological Effects Induced by Head Massage Therapy.
Verification of Psychophysiological Effects Induced by Head Massage Therapy.
| Japan |
Male/female adults
| Adult |
Others
NO
To elucidate the psychophysiological effects on the mind and body of manual massage applied to the head and neck region.
Efficacy
The autonomic nervous system (Pupil measurement (pupillary light reflex), Vascular age assessment.)
The central nervous system (brain age assessment, flicker measurement, postural sway assessment)
Psychological questionnaires (SCL30, VAS, Multiple measurements of emotion using a multiple mood scale (40 questions))
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
| Maneuver |
Perform a 15-minute massage on the head (including the face and the top of the head).
| 30 | years-old | <= |
| 60 | years-old | > |
Male and Female
1. Healthy males and females aged 30 to 59 years old when informed consent.
2. Subjects who can give informed consent to partake in this research, after being provided with an explanation of the protocol detail.
1. Subjects who are in the habit of smoking.
2. Subjects who are receiving medication due to treatment of disease at the time of consent.
3. Subjects who have taken or applied medication for the treatment of any diseases. within the past month (excluding the common cold, but including treatment for hay fever).
4. Subjects who have undergone surgery in the area to be treated (including neck, face, and crown of the head) within the past six months.
5. Subjects currently participating in another clinical trial or those who have participated in a clinical trial within the past month.
6. Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood.
7. Females who are pregnant or lactating, and females who could become pregnant or lactating during test period.
8. Subjects who have symptom of dermatologic disease such as atopic dermatitis.
9. Others who have been determined ineligible by investigator.
20
| 1st name | Hiromi |
| Middle name | |
| Last name | Niwa |
Share Co.Ltd
Representative of Director
136-0063
2107 Galleria Grande, 1-2-11 Ariake, Koto-ku, Tokyo, Japan
03-5530-4445
share28.co@gmail.com
| 1st name | Hiromi |
| Middle name | |
| Last name | Niwa |
Share Co.Ltd
Representative of Director
136-0063
2107 Galleria Grande, 1-2-11 Ariake, Koto-ku, Tokyo, Japan
03-5530-4445
share28.co@gmail.com
Share Co.Ltd
Share Co.Ltd
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo 103-0021, Japan
03-6225-9005
IRB@cpcc.co.jp
NO
| 2024 | Year | 11 | Month | 30 | Day |
Unpublished
No longer recruiting
| 2023 | Year | 10 | Month | 10 | Day |
| 2023 | Year | 10 | Month | 20 | Day |
| 2023 | Year | 12 | Month | 01 | Day |
| 2023 | Year | 12 | Month | 29 | Day |
| 2023 | Year | 11 | Month | 30 | Day |
| 2023 | Year | 12 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060103